Julie V. Miller
Julie V. Miller has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Jonathan W. Boyd
Department of Orthopaedics, School of Medicine, West Virginia University, Morgantown, WV 26506, USA
3 shared publications Julia A. Penatzer
C. Eugene Bennett Department of Chemistry, West Virginia University, Morgantown, WV, USA
2 shared publicationsMackenzie Newman
Department of Orthopaedics, West Virginia University School of Medicine, Morgantown, WV, USA
2 shared publicationsNicole Prince
C. Eugene Bennett Department of Chemistry, West Virginia University, Morgantown, WV, USA
2 shared publicationsAlice A. Han
C. Eugene Bennett Department of Chemistry, West Virginia University, Morgantown, WV, USA
1 shared publicationAlicia R Locker
Health Effects Laboratory Division
1 shared publication
Latest Publications
- Open Access
- 4 February 2022
- Published by Elsevier in Toxicology Reports
- Vol. 9, 238-249
Human health risk assessment of arsenic, cadmium, lead, and mercury ingestion from baby foods
- 4 February 2022
- Published by Elsevier in Toxicology Reports
- Vol. 9, 238-249
Open AccessHuman health risk assessment of arsenic, cadmium, lead, and mercury ingestion from baby foods
- 1 September 2021
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 155, 112421
Corticosterone and chlorpyrifos oxon exposure elicits spatiotemporal MAPK phosphoprotein signaling in a mouse brain
- 1 September 2021
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 155, 112421
Corticosterone and chlorpyrifos oxon exposure elicits spatiotemporal MAPK phosphoprotein signaling in a mouse brain
- Open Access
- 1 June 2021
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 122, 104892
A comprehensive weight of evidence assessment of published acetaminophen genotoxicity data: Implications for its carcinogenic hazard potential
- 1 June 2021
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 122, 104892
Open AccessA comprehensive weight of evidence assessment of published acetaminophen genotoxicity data: Implications for its carcinogenic hazard potential
- Open Access
- 28 March 2020
- Published by Elsevier in Brain, Behavior, & Immunity - Health
- Vol. 4, 100068
Salivary cytokines as a biomarker of social stress in a mock rescue mission
- 28 March 2020
- Published by Elsevier in Brain, Behavior, & Immunity - Health
- Vol. 4, 100068
Open AccessSalivary cytokines as a biomarker of social stress in a mock rescue mission
- Open Access
- 28 May 2018
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 165 (2) , 302-313
The Neuroinflammatory Phenotype in a Mouse Model of Gulf War Illness is Unrelated to Brain Regional Levels of Acetylcholine as Measured by Quantitative HILIC-UPLC-MS/MS
Many veterans of the 1991 Persian Gulf War (GW) returned with a chronic multisymptom illness that has been termed Gulf War Illness (GWI). Previous GWI studies have suggested that exposure to acetylcholinesterase inhibitors (AChEIs) in theater, such as sarin and/or pesticides, may have contributed to the symptomatology of GWI. Additionally, concomitant high physiological stress experienced during the war may have contributed to the initiation of the GWI phenotype. Although inhibition of AChE leading to accumulation of acetylcholine (ACh) will activate the cholinergic anti-inflammatory pathway, the signature symptomatology of GWI has been shown to be associated with neuroinflammation. To investigate the relationship between ACh and neuroinflammation in discrete brain regions, we used our previously established mouse model of GWI, which combines an exposure to a high physiological stress mimic, corticosterone (CORT), with GW-relevant AChEIs. The AChEIs used in this study were diisopropyl fluorophosphate (DFP), chlorpyrifos oxon (CPO), and physostigmine (PHY). After AChEI exposure, ACh concentrations for cortex (CTX), hippocampus (HIP), and striatum (STR) were determined using hydrophilic interaction liquid chromatography with ultraperformance liquid chromatography-tandem-mass spectrometry (MS/MS). CORT pretreatment ameliorated the DFP-induced ACh increase in HIP and STR, but not CTX. CORT pretreatment did not significantly alter ACh levels for CPO and PHY. Further analysis of STR neuroinflammatory biomarkers revealed an exacerbated CORT + AChEI response, which does not correspond to measured brain ACh. By utilizing this new analytical method for discrete brain region analysis of ACh, this work suggests the exacerbated neuroinflammatory effects in our mouse model of GWI are not driven by the accumulation of brain region-specific ACh.
- 28 May 2018
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 165 (2) , 302-313
Open AccessThe Neuroinflammatory Phenotype in a Mouse Model of Gulf War Illness is Unrelated to Brain Regional Levels of Acetylcholine as Measured by Quantitative HILIC-UPLC-MS/MS
Many veterans of the 1991 Persian Gulf War (GW) returned with a chronic multisymptom illness that has been termed Gulf War Illness (GWI). Previous GWI studies have suggested that exposure to acetylcholinesterase inhibitors (AChEIs) in theater, such as sarin and/or pesticides, may have contributed to the symptomatology of GWI. Additionally, concomitant high physiological stress experienced during the war may have contributed to the initiation of the GWI phenotype. Although inhibition of AChE leading to accumulation of acetylcholine (ACh) will activate the cholinergic anti-inflammatory pathway, the signature symptomatology of GWI has been shown to be associated with neuroinflammation. To investigate the relationship between ACh and neuroinflammation in discrete brain regions, we used our previously established mouse model of GWI, which combines an exposure to a high physiological stress mimic, corticosterone (CORT), with GW-relevant AChEIs. The AChEIs used in this study were diisopropyl fluorophosphate (DFP), chlorpyrifos oxon (CPO), and physostigmine (PHY). After AChEI exposure, ACh concentrations for cortex (CTX), hippocampus (HIP), and striatum (STR) were determined using hydrophilic interaction liquid chromatography with ultraperformance liquid chromatography-tandem-mass spectrometry (MS/MS). CORT pretreatment ameliorated the DFP-induced ACh increase in HIP and STR, but not CTX. CORT pretreatment did not significantly alter ACh levels for CPO and PHY. Further analysis of STR neuroinflammatory biomarkers revealed an exacerbated CORT + AChEI response, which does not correspond to measured brain ACh. By utilizing this new analytical method for discrete brain region analysis of ACh, this work suggests the exacerbated neuroinflammatory effects in our mouse model of GWI are not driven by the accumulation of brain region-specific ACh.